$14.10
0.14% today
Nasdaq, Dec 04, 09:51 pm CET
ISIN
US18507C1036
Symbol
CLPT

ClearPoint Neuro Stock price

$14.08
-4.92 25.89% 1M
+1.42 11.22% 6M
-1.30 8.45% YTD
+2.08 17.33% 1Y
+4.64 49.15% 3Y
+4.09 40.94% 5Y
+13.65 3,174.42% 10Y
+13.33 1,777.33% 20Y
Nasdaq, Closing price Wed, Dec 03 2025
+0.74 5.55%
ISIN
US18507C1036
Symbol
CLPT

Key metrics

Basic
Market capitalization
$400.2m
Enterprise Value
$387.5m
Net debt
positive
Cash
$41.5m
Shares outstanding
28.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
11.9 | 10.4
EV/Sales
11.5 | 10.1
EV/FCF
negative
P/B
20.3
Financial Health
Equity Ratio
64.8%
Return on Equity
-74.5%
ROCE
-40.8%
ROIC
-123.0%
Debt/Equity
1.5
Financials (TTM | estimate)
Revenue
$33.6m | $38.4m
EBITDA
$-21.6m | $-13.4m
EBIT
$-22.6m | $-22.7m
Net Income
$-22.2m | $-23.3m
Free Cash Flow
$-11.7m
Growth (TTM | estimate)
Revenue
19.7% | 22.3%
EBITDA
-21.7% | 28.8%
EBIT
-21.8% | -14.9%
Net Income
-23.6% | -23.4%
Free Cash Flow
-18.5%
Margin (TTM | estimate)
Gross
60.4%
EBITDA
-64.4% | -34.8%
EBIT
-67.3%
Net
-66.2% | -60.8%
Free Cash Flow
-34.9%
More
EPS
$-0.8
FCF per Share
$-0.4
Short interest
8.4%
Employees
115
Rev per Employee
$270.0k
Show more

Is ClearPoint Neuro a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

ClearPoint Neuro Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a ClearPoint Neuro forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a ClearPoint Neuro forecast:

Buy
88%
Hold
13%

Financial data from ClearPoint Neuro

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
34 34
20% 20%
100%
- Direct Costs 13 13
18% 18%
40%
20 20
21% 21%
60%
- Selling and Administrative Expenses 29 29
18% 18%
87%
- Research and Development Expense 14 14
28% 28%
41%
-22 -22
22% 22%
-64%
- Depreciation and Amortization 1 1
23% 23%
3%
EBIT (Operating Income) EBIT -23 -23
22% 22%
-67%
Net Profit -22 -22
24% 24%
-66%

In millions USD.

Don't miss a Thing! We will send you all news about ClearPoint Neuro directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ClearPoint Neuro Stock News

Neutral
Accesswire
14 days ago
Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire / November 20, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announ...
Neutral
Seeking Alpha
22 days ago
ClearPoint Neuro, Inc. ( CLPT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Joseph Burnett - President, CEO & Director Danilo D'Alessandro - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Presentation Operator [Audio Gap] comments made on this call may include statements that are forward-looki...
Negative
Seeking Alpha
22 days ago
ClearPoint's third quarter results were weak, which was at least partly due to resource constraints while its new CRO facility was being opened. The near-term outlook for ClearPoint's biopharma business is also now clouded by FDA uncertainty around uniQure's AMT-130. The new CRO facility, PRISM 1.5T clearance, and IRRAS acquisition set ClearPoint up for much stronger growth going forward.
More ClearPoint Neuro News

Company Profile

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

Head office United States
CEO Joseph Burnett
Employees 115
Founded 1998
Website www.clearpointneuro.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today